From recommendation to evidence: Why every treatment decision should link to the trial that changed practice

Clinical recommendations are strongest when clinicians can immediately understand the evidence behind them. Instead of burying references at the end of a guideline, Living Algorithms link important treatment decisions directly to the landmark clinical trials that established the standard of care.

This helps clinicians make decisions with greater confidence while creating a better learning experience for trainees.

Every recommendation begins with a study

Every standard treatment in oncology has a story.

Pembrolizumab for adjuvant renal cell carcinoma.

Osimertinib for EGFR-mutated lung cancer.

Trastuzumab for HER2-positive breast cancer.

These therapies didn't become standards of care overnight. They became standards because a clinical trial changed practice.

Yet when clinicians use many decision support tools today, they often see only the recommendation...not the evidence that led to it.

The evidence is there, it's just difficult to reach

Traditional guidelines often include extensive reference sections. This is important.

But when you're reading a recommendation in clinic, you usually don't want to scroll through dozens of citations to find the one study that matters.

You want to know: "Which trial supports this recommendation?"

And ideally, you want the answer with a single click.

Learning doesn't stop after fellowship

For oncology fellows, landmark trials are the foundation of training. Understanding why a treatment became standard is just as important as remembering what the standard is.

But even experienced oncologists benefit from revisiting the evidence. Perhaps it's a disease they treat infrequently. Perhaps they want to review the inclusion criteria before discussing treatment with a patient.

Or perhaps they simply want a quick refresher before tumor board.

Having immediate access to the pivotal trial makes all of those tasks easier.

Recommendations should teach, not just direct

Clinical decision support shouldn't function like a GPS that simply says: "Turn left."

It should also explain why.

For example: Recommend adjuvant pembrolizumab for selected high-risk patients

Instead of requiring clinicians to search elsewhere, that recommendation could include a direct link to the KEYNOTE-564 trial.

Now the recommendation becomes more than an instruction, it becomes a learning opportunity.

Better evidence at the point of care

Imagine reading a treatment recommendation and seeing:

• The pivotal clinical trial

• The primary publication

• Key efficacy results

• Major eligibility criteria

• Important limitations
  

All without leaving the clinical workflow.

This approach allows clinicians to decide how deeply they want to explore. Some may simply continue with the recommendation. Others may choose to review the original evidence.

Both workflows are supported.

Good decision support respects curiosity

Experienced clinicians are naturally curious. They often ask questions such as:

• Why is this preferred?

• What was the comparator arm?

• Which patients were included?

• Does this patient resemble the trial population?

• How strong is the evidence?
  

Those questions shouldn't require opening multiple websites or searching OpenEvidence, PubMed or UpToDate.

They should be answered exactly where the recommendation appears.

Better for trainees and experts

Embedding landmark trials directly within treatment recommendations benefits every stage of training.

For fellows, it reinforces the connection between evidence and clinical practice. For community oncologists, it provides a rapid refresher when treating an unfamiliar disease. For experts, it offers immediate access to the studies they may want to reference during teaching, tumor boards, or patient discussions.

The recommendation stays concise, but the evidence is just one click away.

Building confidence through transparency

Showing the evidence behind a recommendation also builds trust. Clinicians can see not only what an expert recommends, but why.

This transparency encourages thoughtful decision-making rather than blind acceptance.

The goal isn't to replace clinical judgment. It's to strengthen it.

Connecting evidence to expertise

Clinical trials answer important questions. Expert physicians add another layer. They explain:

• How the evidence applies in practice

• Which patients may benefit most

• Where uncertainty remains

• How they approach situations that weren't studied in the trial
  

Together, evidence and experience provide a richer form of decision support than either can alone.

Bottom line

Every oncology recommendation is built on evidence. Making that evidence immediately accessible helps clinicians learn, verify and make decisions with greater confidence.

The best decision support doesn't ask clinicians to choose between recommendations and research. It connects them.

Try it with your next patient

The next time you read a treatment recommendation, ask yourself: "If I wanted to review the trial that changed practice, how many clicks would it take?"

The fewer, the better.

Because every great recommendation deserves equally accessible evidence.